Gene · 4216
Papers2,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting transcription factors for therapeutic benefit in rheumatoid arthritis. | Front Immunol | 2023 | 37457726 | PubTator, text mining | PubMed |
| Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review). | Oncol Rep | 2023 | 37449515 | PubTator, text mining | PubMed |
| Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis. | Int J Mol Sci | 2023 | 37445988 | PubTator, text mining | PubMed |
| TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells. | Cell Death Dis | 2023 | 37443145 | PubTator, text mining | PubMed |
| Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis. | J Cell Mol Med | 2023 | 37431884 | PubTator, text mining | PubMed |
| The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases. | Front Cell Dev Biol | 2023 | 37427386 | PubTator, text mining | PubMed |
| Metabolic protein kinase signalling in neuroblastoma. | Mol Metab | 2023 | 37414143 | PubTator, text mining | PubMed |
| Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities. | Transl Psychiatry | 2023 | 37407569 | PubTator, text mining | PubMed |
| A weighted distance-based approach for deriving consensus tumor evolutionary trees. | Bioinformatics | 2023 | 37387177 | PubTator, text mining | PubMed |
| Roles of non-coding RNAs in intercellular crosstalk in cardiovascular diseases. | Korean J Physiol Pharmacol | 2023 | 37386827 | PubTator, text mining | PubMed |
| Knockdown of UBQLN1 Functions as a Strategy to Inhibit CRC Progression through the ERK-c-Myc Pathway. | Cancers (Basel) | 2023 | 37370699 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates. | J Fungi (Basel) | 2023 | 37367584 | PubTator, text mining | PubMed |
| The Cell Wall Integrity MAP Kinase Signaling Pathway Is Required for Development, Pathogenicity, and Stress Adaption of the Pepper Anthracnose Fungus Colletotrichum scovillei. | Mycobiology | 2023 | 37359959 | PubTator, text mining | PubMed |
| Research progress on the allergic mechanism, molecular properties, and immune cross-reactivity of the egg allergen Gal d 5. | Front Nutr | 2023 | 37351194 | PubTator, text mining | PubMed |
| SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication. | mBio | 2023 | 37345956 | PubTator, text mining | PubMed |
| HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway. | Cell Commun Signal | 2023 | 37328851 | PubTator, text mining | PubMed |
| Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders. | ACS Omega | 2023 | 37323408 | PubTator, text mining | PubMed |
| Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination. | Front Immunol | 2023 | 37304282 | PubTator, text mining | PubMed |
| Risk prediction for dermatomyositis-associated hepatocellular carcinoma. | BMC Bioinformatics | 2023 | 37259059 | PubTator, text mining | PubMed |
| Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway. | Sci Adv | 2023 | 37256945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4216/papers?page=8